Use of Twitter® in a congress: First experience for French internal medicine

A healthcare social media research article published in Revue de Medecine Interne, June 30, 2016

Title
Use of Twitter® in a congress: First experience for French internal medicine
Authors (alpha)
J Campagne, J. Galland, O. Mangin
Published
June 30, 2016
Journal
Revue de Medecine Interne
DOI
10.1016/j.revmed.2015.10.340
Pubmed
26653331
Altmetric
A healthcare social media research article published in Revue de Medecine Interne, June 30, 2016

Abstract

Twitter(®) is a social "microblogging" network in which users can send and receive updates of up to 140 characters. Nowadays its use in medicine has become common in the United Kingdom and in the USA, particularly in scientific meetings where attendees tweet relevant information from the various lectures. Then, the tweeted information is relayed by followers who may be present or not at the lectures. Using Twitter(®) on the 70th Congress of French Society of Internal Medicine with @MielLorraine and @secretaireMIEL accounts was the first time in internal medicine in France. In total, 825 tweets were posted by both accounts and 59% were original. The two accounts were followed by respectively 12 and 10 followers. People outside the congress were able to get information and to start discussion on many topics. This experience emphasizes the fact that Twitter(®) improves interactions during congresses. Therefore, we should continue on a going forward basis to develop this tool.


Altmetric

The Altmetric Attention Score is based on the attention a research article gets on the internet. Each coloured thread in the circle represents a different type of online attention and the number in the centre is the Altmetric Attention Score. The score is calculated based on two main sources of online attention: social media and mainstream news media.

Healthcare Social Media Research

See the full list of healthcare social media research articles with data from or reference to Symplur.
#hcsmR is a collaboration between Stanford Medicine X and Symplur.